Study: Thousands of men with prostate cancer now choosing ‘active surveillance’

Thousands of men with prostate cancer are choosing to have their disease monitored rather than have radical treatments such as surgery or radiotherapy, according to a report published today. Findings from the 2018 annual report of the Movember Prostate Cancer Outcomes Registry - Australia and New Zealand (PCOR-ANZ) revealed that more than two thirds (69 per cent) of men diagnosed with low-risk prostate cancer during 2015-16 went on active surveillance.

MomenTIM mental health program named among Queensland's best

Congratulations to The Institute for Urban Indigenous Health’s MomenTIM program, which was recognised last week as one of 30 finalists in the 2018 QLD Mental Health Week Achievement Awards.

Prostate Cancer Funding Announcement

Movember Foundation teams up with the Australian Government for $12 million prostate cancer research boost

The Movember innovation placing men at the heart of its design

We’re launching a new product to help men find their way through testicular cancer.

A chance to reflect on the path to progress

Our CEO, Owen Sharp, shares a moment of reflection this World Cancer Day.

TrueNTH: changing the future for men with prostate cancer

TrueNTH is a global collaboration of clinicians, researchers and patients aiming to improve the quality of life and outcomes for men with prostate cancer.

$5.6M invested in the fight to strengthen men's social connections

The Movember Foundation has revealed the names of 13 projects to receive pilot funding as part of the Social Innovators Challenge, a $5.6M AUD investment in projects aimed at strengthening social connections for men across Australia, Canada, and the United Kingdom.

Movember-funded test identifies those at raised risk of testicular cancer

Scientists at The Institute of Cancer Research in London, UK, have found that testing for large numbers of genetic changes can identify men with over a 10-fold increased risk of testicular cancer.

Movember funds promising new blood test for men with prostate cancer

A new blood test, funded in part by the Movember Foundation, could predict which men with advanced prostate cancer will respond to new targeted treatments for the disease.

The Movember Foundation ranked 55 out of top 500 NGOs

For the fourth year running, we've been ranked highly among the top 500 NGOs.

Australia leading the charge in prostate cancer treatment

In the fight against prostate cancer, information is powerful.

Your Funds and Their Impact on Men Living With Cancer

This World Cancer Day, we’re proud to announce the release of our latest impact report describing the key projects accelerating prostate cancer research and outcomes for men living with the disease.